Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics.
Kim S, Bang JI, Boo D, Kim B, Choi IY, Ko S, Yoo IR, Kim K, Kim J, Joo Y, Ryoo HG, Paeng JC, Park JM, Jang W, Kim B, Chung Y, Yang D, Yoo S, Lee HY.
Kim S, et al. Among authors: choi iy.
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3547-3556. doi: 10.1007/s00259-022-05779-9. Epub 2022 Apr 1.
Eur J Nucl Med Mol Imaging. 2022.
PMID: 35362796